发明授权
- 专利标题： Compounds
- 专利标题（中）： 化合物
-
申请号： US13498975申请日： 2010-09-27
-
公开(公告)号： US08778939B2公开(公告)日： 2014-07-15
- 发明人: Paula Louise Nichols , Andrew John Eatherton , Paul Bamborough , Karamjit Singh Jandu , Oliver James Philps , Daniele Andreotti
- 申请人： Paula Louise Nichols , Andrew John Eatherton , Paul Bamborough , Karamjit Singh Jandu , Oliver James Philps , Daniele Andreotti
- 申请人地址： GB Brentford, Middlesex
- 专利权人： Glaxo Group Limited
- 当前专利权人： Glaxo Group Limited
- 当前专利权人地址： GB Brentford, Middlesex
- 代理商 Fang Qian; James C. Kellerman
- 优先权： WOPCT/CN2010/001334 20100902
- 国际申请： PCT/CN2010/001501 WO 20100927
- 国际公布： WO2011/038572 WO 20110407
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; A61K31/4406 ; C07C235/56 ; A61K31/167 ; C07D237/20 ; A61K31/50 ; A61K31/4402 ; C07D239/42 ; A61K31/505
摘要：
The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterized by LRRK2 kinase activity, particularly Parkinson's disease and Alzheimer's disease.
公开/授权文献
- US20120184553A1 NOVEL COMPOUNDS 公开/授权日：2012-07-19
信息查询
IPC分类:
